Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00667589 · ClinicalTrials.gov registry record · Phase 2
Sorafenib-induced Hand- Foot Skin Reaction Treatment
A Phase 2 study, sponsored by Northwestern University.
- Terminated
- Registry status
- Phase 2
- Development phase
- 6
- Enrollment target
NCT00667589 is a Phase 2 study that was terminated before completion, run by Northwestern University. The registered enrollment target is 6 participants.
The verdict
NCT00667589, a Phase 2 study, was terminated before completion, sponsored by Northwestern University.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 6 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate treatments for a rash caused by sorafenib.
Interventions
- DRUG fluocinonide 0.05% cream
- DRUG urea 40% cream
- DRUG tazarotene 0.1% cream
- DRUG bland emollient cream (Udderly smooth® Udder Cream)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2008-06 |
| Est. Completion | 2010-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00667589
The ClinicalTrials.gov registry entry for NCT00667589 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which fluocinonide 0.05% cream is the first listed.
NCT00667589 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00667589 about?
NCT00667589 is a clinical study titled "Sorafenib-induced Hand- Foot Skin Reaction Treatment". The purpose of this study is to evaluate treatments for a rash caused by sorafenib.
What is the current status of trial NCT00667589?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 6 participants. The study started on 2008-06. Estimated completion is 2010-12.
What interventions are being tested in trial NCT00667589?
The interventions under investigation include: fluocinonide 0.05% cream (DRUG), urea 40% cream (DRUG), tazarotene 0.1% cream (DRUG), bland emollient cream (Udderly smooth® Udder Cream) (DRUG).
Who is sponsoring clinical trial NCT00667589?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.